Evidence map›Paper›PMID 31144065›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2020

Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation.

Barbara Kutryb-Zajac, Patrycja Jablonska, Marcin Serocki, Alicja Bulinska, Paulina Mierzejewska, Daniela Friebe, Christina Alter, Agnieszka Jasztal, Romuald Lango, Jan Rogowski and 6 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Immunotherapy in the Context of Aortic Valve Diseases.Cardiovascular drugs and therapy · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Organ Culture Model of Aortic Valve Calcification.Frontiers in cardiovascular medicine · 2021
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Barbara Kutryb-ZajacDepartment of Biochemistry, Medical University of Gdansk, Dębinki 1 Street, 80-211, Gdańsk, Poland.ORCID http://orcid.org/0000-0002-3324-9246
Patrycja JablonskaDepartment of Biochemistry, Medical University of Gdansk, Dębinki 1 Street, 80-211, Gdańsk, Poland.
Marcin SerockiDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Hallera 107 Street, 80-416, Gdańsk, Poland.
Alicja BulinskaDepartment of Biochemistry, Medical University of Gdansk, Dębinki 1 Street, 80-211, Gdańsk, Poland.
Paulina MierzejewskaDepartment of Biochemistry, Medical University of Gdansk, Dębinki 1 Street, 80-211, Gdańsk, Poland.
Daniela FriebeDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Universitätsstr. 1, 40225, Düsseldorf, Germany.
Christina AlterDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Universitätsstr. 1, 40225, Düsseldorf, Germany.
Agnieszka JasztalJagiellonian Centre for Experimental Therapeutics, Bobrzyńskiego 14 Street, 30-348, Kraków, Poland.
Romuald LangoDepartment of Cardiac Anesthesiology, Medical University of Gdansk, Dębinki 7 Street, 80-211, Gdańsk, Poland.
Jan RogowskiChair and Clinic of Cardiac and Vascular Surgery, Medical University of Gdansk, Dębinki 7 Street, 80-211, Gdańsk, Poland.
Rafal BartoszewskiDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Hallera 107 Street, 80-416, Gdańsk, Poland.
Ewa M SlominskaDepartment of Biochemistry, Medical University of Gdansk, Dębinki 1 Street, 80-211, Gdańsk, Poland.
Stefan ChlopickiJagiellonian Centre for Experimental Therapeutics, Bobrzyńskiego 14 Street, 30-348, Kraków, Poland.
Jürgen SchraderDepartment of Molecular Cardiology, Heinrich-Heine-University Düsseldorf, Universitätsstr. 1, 40225, Düsseldorf, Germany.
Magdi H YacoubHeart Science Centre, Imperial College of London at Harefield Hospital, Harefield, Middlesex, UB9 6JH, UK.
Ryszard T SmolenskiDepartment of Biochemistry, Medical University of Gdansk, Dębinki 1 Street, 80-211, Gdańsk, Poland. rt.smolenski@gumed.edu.pl.ORCID http://orcid.org/0000-0002-0190-9414
Gdańsk Medical University · PLHeinrich Heine University Düsseldorf · DEJagiellonian University · PLHarefield Hospital · GB

Funding

National Science Centre of Poland 2016/22/M/NZ4/00678Polish Ministry of Science and Higher Education for the Medical University of Gdansk MN-01-0343/08/256
6 · The paper itself

Abstract

backgroundExtracellular nucleotide metabolism contributes to chronic inflammation, cell differentiation, and tissue mineralization by controlling nucleotide and adenosine concentrations and hence its purinergic effects. This study investigated location-specific changes of extracellular nucleotide metabolism in aortic valves of patients with calcific aortic valve disease (CAVD). Individual ecto-enzymes and adenosine receptors involved were analyzed together with correlation with CAVD severity and risk factors.

resultsNucleotide and adenosine degradation rates were adversely modified on the aortic surface of stenotic valve as compared to ventricular side, including decreased ATP removal (1.25 ± 0.35 vs. 2.24 ± 0.61 nmol/min/cm

conclusionsThis work highlights profound changes in extracellular nucleotide and adenosine metabolism in CAVD. Altered extracellular nucleotide hydrolysis and degradation of adenosine in stenotic valves may affect purinergic responses to support a pro-stenotic milieu and valve calcification. This emphasizes a potential mechanism and target for prevention and therapy. .

Indexed as

5'-NucleotidaseAdenosineAdenosine DeaminaseAdenosine MonophosphateAdenosine TriphosphateAdultAgedAnimalsAntigens, CDAortic ValveAortic Valve StenosisApyraseCalcinosisCells, CulturedDeaminationDisease Models, Animal5'-NucleotidaseADA protein, humanAdenosineAdenosine DeaminaseAdenosine MonophosphateAdenosine TriphosphateAntigens, CDApyraseCD39 antigenectonucleotide pyrophosphatase phosphodiesterase 1GPI-Linked ProteinsHydrolasesNT5E protein, humanPhosphoric Diester HydrolasesPyrophosphatasesReceptors, LDLReceptors, Purinergic P1AdenosineAdenosine deaminaseAdenosine receptorsCalcific aortic valve diseaseEcto-5′-nucleotidaseEcto-nucleoside triphosphate diphosphohydrolase 1

Identifiers

PMID31144065
PMCPMC6989624
OpenAlexW2947649297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.